Public Profile

RECORDATI

Recordati S.p.A., a prominent player in the pharmaceutical industry, is headquartered in Luxembourg (LU) and operates extensively across Europe, North America, and other global markets. Founded in 1926, Recordati has established itself as a leader in the development and marketing of innovative medicines, particularly in the fields of rare diseases and specialty pharmaceuticals. The company’s core offerings include a diverse range of prescription drugs, with a strong emphasis on treatments for rare diseases, urology, and cardiovascular conditions. Recordati's commitment to research and development sets it apart, enabling the introduction of unique therapies that address unmet medical needs. With a robust market position, Recordati has achieved significant milestones, including strategic acquisitions and partnerships that enhance its portfolio and global reach.

DitchCarbon Score

How does RECORDATI's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

63

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

RECORDATI's score of 63 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.

97%

Let us know if this data was useful to you

RECORDATI's reported carbon emissions

In 2023, RECORDATI reported total carbon emissions of approximately 36,607,000 kg CO2e from Scope 1 and 9,811,000 kg CO2e from Scope 2, alongside 1,566,000 kg CO2e from Scope 3 emissions. This reflects a commitment to transparency in their environmental impact, with a total of about 48,984,000 kg CO2e for Scope 1 and 2 combined. RECORDATI has set ambitious climate targets, aiming for a 42% reduction in Scope 1 and Scope 2 greenhouse gas emissions by 2030, using 2023 as the baseline year. This target aligns with the Science Based Targets initiative (SBTi) and is designed to contribute to global efforts to limit warming to 1.5°C. Additionally, the company has committed to measuring and reducing its Scope 3 emissions, which encompass indirect emissions from its value chain. In previous years, RECORDATI's emissions have shown fluctuations, with Scope 1 emissions recorded at approximately 37,768,000 kg CO2e in 2022 and 36,607,000 kg CO2e in 2023. Scope 2 emissions were about 10,002,000 kg CO2e in 2022, indicating a focus on reducing energy-related emissions. Overall, RECORDATI's climate commitments reflect a proactive approach to sustainability, with clear targets aimed at reducing their carbon footprint and contributing to a more sustainable future.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20172018201920202021202220232024
Scope 1
34,458,000
00,000,000
00,000,000
00,000,000
00,000
00,000,000
00,000,000
00,000,000
Scope 2
12,384,000
00,000,000
0,000,000
0,000,000
0,000
0,000,000
0,000,000
0,000,000
Scope 3
-
-
-
-
-
0,000,000
0,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. RECORDATI's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for RECORDATI is in LU, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

RECORDATI is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Mercer

CA
Paper and paper products
Updated about 21 hours ago

Churchill Downs Incorporated

US
Recreational, cultural and sporting services (92)
Updated about 21 hours ago

Almirall

ES
Pharmaceutical Preparation Manufacturing
Updated about 21 hours ago

Alnylam Pharmaceuticals

US
Medical, precision and optical instruments, watches and clocks (33)
Updated about 21 hours ago

Actelion Ltd

CH
Pharmaceutical Preparation Manufacturing
Updated about 21 hours ago

Horizon Therapeutics Public Limited Company

IE
Health and social work services (85)
Updated about 2 months ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers